{Reference Type}: Journal Article
{Title}: Cooperation with rheumatologists on intensive systemic treatment for psoriatic arthritis-related panuveitis with retinal vasculitis: a case report.
{Author}: Wu PY;Kao CC;Sheu SJ;Wu PY;Kao CC;Sheu SJ;Wu PY;Kao CC;Sheu SJ;
{Journal}: BMC Ophthalmol
{Volume}: 22
{Issue}: 1
{Year}: Feb 2022 23
{Factor}: 2.086
{DOI}: 10.1186/s12886-022-02313-1
{Abstract}: <B>BACKGROUND: </B>Patients with psoriatic arthritis (PsA) may develop uveitis, a potentially serious ocular complication. PsA-related uveitis may result in significant morbidity and even vision loss if underdiagnosed or under-treated. We presented a case with long-standing recurrent uveitis and retinal vasculitis successfully managed by fortified systemic immunomodulators for systemic PsA.<BR><B>METHODS: </B>A 47-year-old woman was referred under the impression of acute anterior uveitis in her right eye in recent one month. Ocular examinations showed panuveitis in both eyes with intense vitreous opacity in her right eye. Fundus fluorescence angiography revealed retinal vasculitis in both eyes. Systemic surveys excluded the possibility of infection but showed an elevated inflammation marker. With intensive immunosuppressive treatment, inflammation resolved and the vision improved.<BR><B>CONCLUSIONS: </B>Our case highlights not only the importance of intensified systemic therapy in treating PsA-related uveitis but the importance of multidisciplinary collaboration. Recurrent uveitis may be an indicator of disease activity prior to other inflammatory markers.